Publications found:
32,992
Sort by:
Research Report on China Antidiabetic Drug Market, 2014-2018
US$ 2,400.00
... and cure to diabetes become more difficult. The prevalence rate of diabetes in China increased from less 1% in 1980 to about 5.5% in 2022, 11% in 2013, which become the ... . The CAGR in 2009-2013 exceeded 17%. CRI estimates the CAGR of China antidiabetic drug market size will keep 15%. For global pharmaceutical ...
December 2013
60 pages
Market Access for Orphan Drugs: assessing the global landscape
US$ 595.00
... high cost of orphan drugs. International and regional regulations are also hurdles to be overcome, despite harmonisations efforts by agencies. In Market Access for Orphan Drugs: Assessing the Global Landscape, FirstWord goes around the world to lay bare the market access issues affecting orphan drug developers in the ...
November 2013
100 pages
Russian Pharmaceutical Market Outlook to 2017
US$ 800.00
... players will continue to boost the market. According to our report, “Russian Pharmaceutical Market Outlook to 2017”, the pharmaceutical market is anticipated to grow at a CAGR ... focuses on the emerging pharmaceutical clusters in Russia and the role they will play in shaping the market. The market has been ...
November 2013
80 pages
China Large Volume Parenteral (LVP) Industry Report, 2013-2015
US$ 1,800.00
... context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which ... balance injection, therapeutic injection, nutrition injection, injection for blood volume expansion and peritoneal dialysis fluid injection and other market ...
November 2013
65 pages
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023
US$ 3,000.00
... reach $143.7bn by 2023. GMR Data’s latest report 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ explains just how ... Within GMR Data’s 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ we analyse the key cancer drugs and treatments in the market currently and ...
November 2013
243 pages
2014 Nucleic Acid Testing Market: Strategic Assessments of Leading Strategic Suppliers
US$ 2,800.00
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as ... assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, ...
November 2013
549 pages
Physician Views: What opportunity for Novo Nordisk's Victoza in obesity?
US$ 695.00
... mixed opinions on the commercial opportunity, but one of the more intriguing near- ... the US within the next few months, this week's Physician Views poll targets general practitioners and internal ... obesity (and based on available Phase III data), in what percentage of obese patients would you consider prescribing ...
November 2013
Research Report on China Osteoporosis Drug Market, 2013-2017
US$ 1,800.00
... vitamin D and analogues, and calcitonins always took up above 98% shares of China osteoporosis drug market. The market share of bisphosphonates increased at the ... global pharmaceutical enterprises, they will find huge market opportunities in China. Through this report, the readers can acquire the following ...
November 2013
30 pages
2014 Analysis of the Global Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... (test volumes, sales forecasts, supplier shares) $5,500. This new 318-page report from Venture Planning Group contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic ...
November 2013
318 pages
2014 Analysis of the UK Drugs of Abuse Testing Market: Hospitals and Commercial Labs
US$ 1,960.00
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
260 pages
2014 Analysis of the European Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
300 pages
2014 Analysis of the Global Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... volumes, sales forecasts, supplier shares) $5,500. This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and ...
November 2013
313 pages
2014 Analysis of the European Therapeutic Drug Monitoring (TDM) Market : Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 291-page report from Venture Planning Group provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and ...
November 2013
291 pages
US Lung Cancer Drug Pipeline Analysis
US$ 1,800.00
... annual statistics published, an estimated 201,144 people in the United States were diagnosed with lung cancer. This figure included 107,164 men and ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Lung Cancer Drug Pipeline Analysis ...
November 2013
385 pages
US Colorectal Cancer Drug Pipeline Analysis
US$ 1,500.00
... that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions ... market based upon development process. Following parameters for each drug profile in development phase are covered in “US Colorectal Cancer Drug Pipeline ...
November 2013
242 pages
US Parkinson's Disease Drug Pipeline Analysis
US$ 1,500.00
... in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Parkinson’s Disease Drug Pipeline Analysis ...
November 2013
241 pages
Pharmaceutical Companies Directory-Global-Excel Format
US$ 297.00
This is an excel file with over 5,000 global pharma industry contacts at 1,600 pharmaceutical companies around the globe. This Directory provides profiles of the international leaders in the pharma industry in Microsoft Excel format so the data can be searched, sorted and exported for other ...
October 2013
5000 pages
Pharmaceutical Industry in China Q3 2013 - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
US$ 3,400.00
“Pharmaceutical Industry China Q3 2013 – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, ... position within the market Top Five Contract Pharmaceutical Export Markets of China Major players within China’s leading therapeutic markets (e.g., cancer, allergy, liver ...
October 2013
145 pages
Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013
US$ 3,400.00
“Pharmaceutical Market: India, A Competitive Industry Analysis Q3 2013” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises ...
October 2013
161 pages
Pharmacy Retail Market in Philippines 2013
US$ 1,950.00
... . Netscribes’ latest market research report titled Pharmacy Retail Market in Philippines 2013 identifies the healthcare scenario, more specifically, the pharmacy retail scenario in the Philippines. The sector is dotted ...
October 2013
75 pages
Global RNAi Drug Pipeline Analysis
US$ 1,500.00
... location. “Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. ... Drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Global RNAi Drug Pipeline ...
October 2013
250 pages
Global DNA Vaccine Pipeline Analysis
US$ 1,500.00
... West Nile Virus to be used in horses was approved in 2005. 'Global DNA Vaccine Pipeline Analysis' by PNS Pharma gives comprehensive insight on the various ... holders to identify and analyze the available investment opportunity in the DNA vaccine market based upon development process. Following parameters for ...
October 2013
130 pages
US Orphan Drug Pipeline Analysis
US$ 1,800.00
... from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the ... increasing, thus increasing the profit margins in the future. “US Orphan Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ...
October 2013
880 pages
Global Infertility Drug Pipeline Analysis
US$ 1,000.00
... drugs and treatment. The most lucrative markets for infertility drugs are the emerging nations such as India, Brazil, China and Mexico, ... pool of people being affected by lifestyle diseases, thus leading to infertility. “Global Infertility Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...
October 2013
60 pages
Orphan Drugs for Cancer Pipeline Analysis
US$ 1,800.00
... patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group ... drug profile in development phase are covered in “Orphan Drugs for Cancer Pipeline Analysis” research report: Drug Profile Overview Alternate Names for Drug ...
October 2013
855 pages
Global HIV Infection Drug Pipeline Analysis
US$ 1,500.00
... to identify and analyze the available investment opportunity in the HIV Infection drug market based upon development process. Following parameters for each drug profile in clinical development phase are covered in “Global HIV Infection Drug Pipeline Analysis” research report: Drug ...
October 2013
300 pages
US Alzheimer Drug Pipeline Analysis
US$ 2,000.00
... observed that almost 1 in 8 people coming under the 65+ age group are patients of Alzeimer’s disease. Amongst the population in the 80+ age group, almost ... market based upon development process. Following parameters for each drug profile in development phase are covered in “US Alzheimer Drug Pipeline Analysis” ...
October 2013
348 pages
US Prostate Cancer Drug Pipeline Analysis
US$ 1,800.00
... Clinical Trial Owner / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes US Prostate Cancer Drug Pipeline by Clinical Phase: Research: 11 Preclinical: 44 Unknown Phase: 4 Phase 0: 1 Phase-I: 22 Phase-I/II: 18 Phase-II: 53 Phase-II/III: 1 Phase-III:14 Marketed: 13
October 2013
375 pages
US Breast Cancer Drug Pipeline Analysis
US$ 1,800.00
... and new therapies would account for more than 25% of the overall market for breast cancer drug treatments. “US Breast Cancer Drug Pipeline Analysis” by ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Breast Cancer Drug Pipeline ...
October 2013
480 pages
Europe Breast Cancer Drug Pipeline Analysis
US$ 1,800.00
... opportunity in the Breast Cancer drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Europe Breast Cancer Drug Pipeline Analysis” research report: Drug Profile Overview Alternate Names ...
October 2013
380 pages
Pharmaceutical Companies Directory-USA-Excel Format
US$ 197.00
This is a directory of 1,333 professionals in U.S. Pharmaceutical companies in Microsoft Excel format. It is searchable, and exportable for use in mailings and lead generation. This database includes the following fields, where available: Company name Mailing address City State Zip (easy sorting by ...
September 2013
1333 pages
Global Facial Injectables Market Report: 2013 Edition
US$ 800.00
... Galderma, Bloomage BioTechnology and Beijing Emeical BioTechnology. This report provides an analysis of the global facial injectables market. It discusses major challenges faced by the industry along ...
September 2013
65 pages
The U.S. Medical Marijuana Market
US$ 995.00
... 2018. There are the about 1,700-2,000 medical marijuana retail dispensaries now operating in the United States, operating in a very uncertain but improving ... public opinion and tax revenue-hungry states are fueling optimism about the medical marijuana (cannabis) market, but significant hurdles remain. ...
September 2013
129 pages
Research Report on China Measles, Mumps and Rubella (MMR) Vaccine Market, 2013-2017
US$ 1,200.00
... (incidence rate: below 1/100,000,000). In 2012, China's lot released volume of measles vaccines reached 8.651 million person-servings, decreasing ... vaccines manufactured by Merck violated the approval process of imported vaccines in China because it lacked alerts in the specification and existed safety risks. ...
September 2013
20 pages
